CO-NEWMONT-CORP
14.4.2022 17:02:12 CEST | Business Wire | Press release
Today, Newmont Corporation (NYSE: NEM, TSX: NGT) launched its 2021 Sustainability Report as part of its suite of reports on the Company’s environmental, social and governance (ESG) practices in key areas that include health, safety and security, human rights, the environment, social acceptance, governance, and inclusion and diversity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220414005599/en/
“Newmont has a long tradition of setting and transparently reporting against public targets. With this report, we offer stakeholders a clear and comprehensive understanding of our most material sustainability topics,” said Tom Palmer, Newmont President and CEO. “As the world’s leading gold company, our ESG practices are woven into the fabric of our company as we work to deliver on our purpose: to create value and improve lives through sustainable and responsible mining.”
Highlights of Newmont’s 2021 Sustainability Report:
- Commitment to health and safety: Achieved zero work-related fatalities for the third year in a row. Further embedded our Fatality Risk Management program with a focus on verifying the critical controls that prevent fatalities and coaching frontline leaders to provide visible, felt leadership.
- Response to COVID-19: Continued to put the health, safety and wellbeing of our workforce and host communities at the heart of every decision the Company made. Newmont strongly supported COVID-19 vaccines as they became available and adopted the position of requiring all employees and third-party workers to be fully vaccinated. With contributions through Newmont’s Global Community Support Fund, the Company supported COVID-19 testing facilities, vaccine awareness campaigns and vaccine rollouts in areas near our operations.
- Sustainability-linked financial performance: Established the industry’s first sustainability-linked bond, holding Newmont to account for meeting our 2030 emissions reductions targets and to achieve gender parity in senior leadership roles by 2030. This represents the next step in aligning our business to our commitments and values by linking the interest rate payout to our performance on key ESG priorities.
- Value sharing: Newmont played an important role in creating economic value in host communities and jurisdictions, contributing $10.8 billion to its workforce, host communities and jurisdictions through wages and benefits, operating costs, capital spend, royalties and taxes. This includes spending $1.4 billion with local and Indigenous suppliers, $21.9 million in community investments and providing ongoing opportunities for local and Indigenous employment, along with an additional $3.5 million from Newmont’s Global Community Support Fund.
Newmont’s sustainability efforts continue to be recognized by several leading independent organizations:
- Recognized as a leading gold miner for the seventh consecutive year in the Dow Jones Sustainability Index (DJSI) while continuing to be ranked as the top mining company on FORTUNE’s list of the World’s Most Admired Companies;
- Earned a rating of “AA” from MSCI, putting Newmont in the top quartile for precious metals and mining;
- Listed as sixth overall and the top mining company in 3BL’s 100 Best Corporate Citizens;
- Included in Bloomberg’s Gender-Equality Index (GEI) for Newmont’s efforts to advance women in the workplace for the fourth successive year;
- Named to the JUST 100 as one of America’s most JUST companies by JUST Capital and CNBC, included in the JUST 100 and named Industry Leader for 2022; and
- One of the most transparent companies in the S&P 500, according to Bloomberg’s ESG Disclosure Score.
Newmont’s 2021 Sustainability Report is written in accordance with the GRI 2016 Universal Standards Core option, the GRI Mining and Metals Sector Supplement, the Sustainability Accounting Standards Board (SASB) Metals and Mining standards and is externally assured by an independent third-party. Additionally, Newmont’s sustainability report aligns with ICMM’s Mining Principles’ Performance Expectations and the World Gold Council’s Responsible Gold Mining Principles.
The full 2021 Sustainability Report, along with the ESG data tables and comprehensive GRI and SASB content indices, is available for download on Newmont’s website .
About Newmont
Newmont is the world’s leading gold company and a producer of copper, silver, zinc and lead. The Company’s world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in North America, South America, Australia and Africa. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social and governance practices. The Company is an industry leader in value creation, supported by robust safety standards, superior execution and technical expertise. Newmont was founded in 1921 and has been publicly traded since 1925.
At Newmont, our purpose is to create value and improve lives through sustainable and responsible mining. To learn more about Newmont’s sustainability strategy and initiatives, go to www.newmont.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220414005599/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 16:37:00 CEST | Press release
Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory standardsFDA grants Compass NDA rolling submission and review request, based on Phase 3 dataCNPV awarded for COMP360, Compass’ proprietary formulation of synthetic psilocybin, for treatment-resistant depression (TRD)CNPV further accelerates momentum and Compass is confident and ready to deliver for patients Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be en
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
